BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Bleomycin
,
rs3825942
,
ERBB2
,
Apoptosis
,
Lung cancer
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RTKs
Summary
General Info
Curated Studies
Most Correlated Studies
Thyroid papillary carcinoma TPC-1 cells treated with receptor tyrosine kinase inhibitor RPI-1
T-cell acute lymphoblastic leukemia primary samples from bone marrow or peripheral blood
Non-small cell lung cancer NCI-H1299 cells with siRNA knockdown of EPHA2 and treated with HGF
Gastric cancer cells treated with MEK inhibitor PD0325901
Gastric cancer and down syndrome MET-amplified KATO II cells with shRNA-mediated ERBB3 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway.
In situ modeling of acquired resistance to RTK/RAS pathway targeted therapies.
Breaking Oncogene Addiction: Getting RTK/RAS-Mutated Cancers off the SOS.
Role of noncanonical Wnt ligands and Ror-family receptor tyrosine kinases in the development, regene…
TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancer…
Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Ter…
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negativ…
Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ